> ## Content Index > Fetch the complete content index at: https://www.theaidirectory.com.au/llms.txt > Use this file to discover other available public pages before exploring further. # DeepScribe Review Australia 2026: Best-in-Class for Specialty Care — If You Can Get It - URL: https://www.theaidirectory.com.au/review-deepscribe-australia-2026/ - Published: 2026-06-25T23:00:00.000Z - Updated: 2026-10-09T06:29:21.000Z - Description: DeepScribe earns a 98.8 KLAS score and genuine praise in oncology, cardiology, and urology. It is also an enterprise-only US product with no Australian pricing, no AU data hosting, and no Best Practice or MedicalDirector integration. For most Australian clinicians, it is not a practical option today - Author: Adam - Tags: Healthcare & Medical AI, AI Medical Scribes, AI Reviews, #review **12**/25 ★★★☆☆ Good DeepScribe Inc. Verified 26 Jun 2026 Value for Money**2**/5 Ease of Use**3**/5 Feature Depth**5**/5 Australian Fit**1**/5 Reliability & Support**1**/5 Pricing Pricing not vendor-verified — see the pricing table **The gate:** Five stars need 21+ and Australian Fit of at least 4/5. [Skip to the verdict ](#verdict) > ⚠️ **PRICING NOT VENDOR-VERIFIED — 6 September 2026.** DeepScribe publishes no pricing and its site exposes almost nothing to a fetch (re-checked 6 September 2026). The cost range below is a third-party estimate and is labelled as such. Treat every price in this review as indicative, confirm the live figure at checkout, and read the verdict knowing the pricing criterion rests on unconfirmed numbers. See our [Verification Standard](https://www.theaidirectory.com.au/methodology/). > > **Verdict (TL;DR):** DeepScribe is the most highly rated ambient AI scribe for complex specialty medicine, with a 98.8 KLAS Spotlight score and deep integration with US oncology, cardiology, urology, and neurology workflows. The product is genuinely impressive. The access problem is that DeepScribe is an enterprise product sold via custom quotes to healthcare organisations — there is no individual clinician plan, no published pricing, and no confirmed path for an Australian practice to buy it. Data is hosted in the United States, and there are no integrations with Best Practice or MedicalDirector. Australian clinicians in a large private hospital considering US specialty EHR integrations could explore it, but there is no off-the-shelf pathway for the typical Australian GP or specialist in private practice. **This tool does not replace clinical judgement or qualified medical advice.** > > **Score: 12/25 — ⭐⭐⭐ Good** > > *Last reviewed: 26 June 2026 by Adam.* --- ## What DeepScribe is DeepScribe is an ambient clinical documentation platform built specifically for complex specialty care. Its headquarters is in San Francisco (82 2nd Street). It describes itself as an "ambient OS" — a clinical operating system that captures the conversation between clinician and patient, drafts structured specialty-specific notes, suggests clinical codes, and pushes structured data directly into discrete EHR fields. Where most AI scribes are generalist tools that cover many specialties with the same template logic, DeepScribe is explicitly built for the hard specialties: oncology, cardiology, urology, gastroenterology, neurology, and orthopaedics. It has captured more than 5 million oncology visits in the US, and claims 85% of clinicians choose it over alternatives in its target segments. Its KLAS Spotlight score — an independent healthcare IT benchmarking score — was 98.8 out of 100 as of the DeepScribe website's current claim. That is the highest in the ambient AI scribe category. DeepScribe's 2026 product suite includes: - **AI Medical Scribe** — ambient transcription with specialty-specific note generation - **SmartPrep** — pre-visit intelligence, pulling forward longitudinal record context before the consultation - **AI Coding** — automated E/M, ICD-10, and HCC code generation - **Customisation Studio** — provider-level note style learning and fine-tuning - **DeepScribe Assist** — quality and value-based care insights at the point of care EHR integrations are deep in the US: Epic, iKnowMed, OncoemR, and others are named on the website. The integrations push structured data into discrete fields — not copy-paste. This is where DeepScribe differentiates from lighter scribes. --- ## What it costs in Australia DeepScribe does not publish pricing. The product is sold via enterprise contract. There is no individual clinician plan, no free trial, and no pricing page. To engage, you contact sales and receive a custom quote. For Australian clinicians or health organisations, the access path is: 1. Contact DeepScribe via deepscribe.ai/contact 2. Request a demo and indicate Australian market interest 3. Negotiate a custom enterprise agreement There is no confirmed pathway for Australian healthcare organisations. DeepScribe's named customers are all US health systems — Ochsner Health, Texas Oncology, Covenant Healthcare, Pearl Health. There is no listed Australian customer. **Cost estimate:** (third-party estimate — not published by the vendor) Third-party sources suggest enterprise ambient AI scribes in the US cost between US$300 and US$800 per provider per month at scale. At USD 1 = AUD 1.40 and with GST added (×1.10), an indicative range is approximately A$420–1,120 per provider per month. These figures are highly uncertain — contact DeepScribe directly for any quote relevant to an Australian context. --- ## How it works in practice For clinicians in US health systems that have deployed DeepScribe, the workflow is: open the app, start the consult, and speak naturally. DeepScribe captures the conversation with what the company describes as context awareness — it pulls in prior notes, labs, imaging, medications, and diagnoses from the patient's EHR before the visit, and uses that context to make the current note more precise. SmartPrep generates pre-visit summaries so the clinician walks in already briefed on the patient's history, current medications, and outstanding items. Post-visit, AI Coding suggests E/M codes, HCC codes, and ICD-10 codes based on the documented encounter. The Customisation Studio adapts to each provider's style over time. Unlike simpler scribes where you apply a template, DeepScribe claims to learn voice and format preferences iteratively — so notes become more accurate to each clinician's style without manual intervention. The result, according to user testimony in US health systems, is a significant reduction in documentation time for complex specialty visits. An oncology note that might take 15 minutes to write can be reduced to two or three minutes of review. For Australian clinicians, this workflow description is largely hypothetical — there is no confirmed path to access the product, and the EHR integrations it relies on (Epic, iKnowMed, OncoemR) are not the primary platforms in most Australian private specialist practices. --- ## What it does well **Specialty depth that others cannot match.** Most AI scribes are built for primary care. DeepScribe is genuinely built for the complexity of oncology or cardiology. It understands the structure of a treatment summary, an interval history, or a chemotherapy visit note. That level of specialisation matters when the alternative is a general-purpose template that misses clinical nuance. **Context-awareness from the patient record.** SmartPrep pulling longitudinal record context before the visit is a meaningful clinical feature — not just documentation speed, but visit preparation quality. No other scribe reviewed in this roundup has an equivalent pre-visit intelligence layer. **Coding automation.** Automated E/M, ICD-10, and HCC coding pushes directly into EHR fields is genuinely useful for US billing workflows. It reduces coding errors and time spent on post-visit administrative tasks. **Highest KLAS score in the category.** A 98.8 KLAS Spotlight score is not a marketing claim — KLAS is an independent benchmarking organisation that interviews clinicians at customer sites. A near-perfect score at scale reflects real user satisfaction. **Enterprise-grade security.** SOC 2 certification, AES-256 end-to-end encryption, and HIPAA compliance are confirmed. DeepScribe has a published security practices page and a trust portal. --- ## What it doesn't do well **No individual or small-practice access.** DeepScribe is an enterprise product. A solo GP or specialist in a five-doctor practice cannot sign up. The entry point is a healthcare organisation with a sales process. This is a structural exclusion for most Australian clinicians considering a trial. **No published pricing.** Without pricing transparency, it is impossible to compare value on a per-provider basis. The enterprise sales model means cost is opaque until you are well into a procurement process. For Australian organisations that require price disclosure before engaging, this creates a barrier. **No Australian EHR integration.** Best Practice and MedicalDirector are the primary GP clinical systems in Australia. Epic is rare in Australian private practice (some large hospital networks are deploying it, but it is not common among specialists or GPs). DeepScribe's AU integration story is effectively non-existent for the majority of Australian clinical settings. **US data hosting, no AU residency option confirmed.** DeepScribe's data centres are in the US. There is no published Australian data residency option. For Australian healthcare organisations subject to state health department data policies or Privacy Act obligations, this is a blocking issue unless the company can offer a specific AU solution. **No confirmed AU availability.** DeepScribe does not list Australia as a market on its website. No Australian customer is named. Engagement with Australian clinicians or health systems is (not confirmed by the vendor) — contact DeepScribe directly to confirm. **No free trial.** There is no way to evaluate the product without entering an enterprise sales process. For a clinician researching options independently, this is a practical dead end. **This tool does not replace clinical judgement or qualified medical advice.** DeepScribe's AI-generated notes and coding suggestions are first drafts and clinical decision support inputs. The clinician retains full professional responsibility for every note that enters the medical record and every clinical decision made during the visit. --- ## Australian fit — patient privacy, TGA/AHPRA, AU EHR integration **Data residency:** Patient data is hosted in the US. DeepScribe's security practices confirm US-based data centres with physical security and AES-256 encryption. No Australian data residency option is published. For Australian health organisations, this is a material issue under the Privacy Act 1988, APP 8 (cross-border disclosure), and any applicable state health data policies. **Privacy Act 1988 / My Health Record Act:** No published compliance position for Australian law. DeepScribe is HIPAA-compliant. Clinicians who generate or share information connected to a patient's My Health Record should seek advice on whether an offshore platform is permissible. **TGA / AHPRA:** DeepScribe's AI Coding feature generates coding suggestions — these are clinical and administrative tools, not diagnostic devices. DeepScribe is not listed on the ARTG. Clinicians retain full responsibility for note accuracy and clinical decision-making. AHPRA's professional standards on record-keeping apply without exception. **AU EHR integration:** No integration with Best Practice or MedicalDirector. EHR integrations listed on the website are US-specific (Epic, iKnowMed, OncoemR). **AU availability:** Not confirmed. No Australian customers listed. Contact sales to explore. **Support:** US-based. No AU business hours confirmed. Australian Fit score: **1/5** --- ## Alternatives DeepScribe is an enterprise-only product not yet available in Australia. If you are a specialist or large health organisation looking for strong specialty scribe performance, consider: - [**Heidi Health**](https://www.theaidirectory.com.au/review-heidi-health-australia-2026/) — Melbourne-built, onshore data, native Best Practice and MedicalDirector integration, available now with a free tier (22/25). Best for GPs and allied health; growing specialty support. - [**Lyrebird Health**](https://www.theaidirectory.com.au/review-lyrebird-health-australia-2026/) — Melbourne-built, AWS Sydney data hosting, strong privacy story, Lite tier available (21/25). Good fit for specialists who want clean AU data residency. - [**Abridge**](https://www.theaidirectory.com.au/review-abridge-australia-2026/) — Another US enterprise specialty scribe (Epic-integrated, hospital-focused). Also not available in Australia in a standard way, but worth monitoring if your organisation is deploying Epic (14/25). --- ## Bottom line DeepScribe is the best ambient AI scribe in the world for complex specialty medicine. The KLAS score, the oncology depth, the SmartPrep intelligence layer, and the coding automation represent a product that is genuinely further along than the general-purpose competition. If you work in a large US health system using Epic or iKnowMed, it is a strong candidate. For Australian clinicians, the honest assessment is that DeepScribe is not a realistic option today. No published Australian availability, no confirmed AU data hosting, no Best Practice or MedicalDirector integration, enterprise-only access with no individual plan, and no pricing transparency add up to a product that most Australian practices cannot buy or evaluate. If you run a large private hospital or specialist network that is deploying Epic and considering US-sourced enterprise tools, it is worth a conversation with DeepScribe's sales team. For everyone else, Heidi Health or Lyrebird Health is the practical starting point. **This tool does not replace clinical judgement or qualified medical advice.** --- ## Score | Criterion | Score | Notes | | --------------------- | ----- | ------------------------------------------------------------------------------------ | | Value for Money | 2/5 | No pricing transparency; enterprise-only; no individual plan or free trial | | Ease of Use | 3/5 | Excellent when deployed, but no accessible onboarding path for Australian clinicians | | Feature Depth | 5/5 | Deepest specialty AI in the category; SmartPrep, AI Coding, KLAS 98.8 | | Australian Fit | 1/5 | US data hosting; no AU EHR integration; no confirmed AU availability | | Reliability & Support | 1/5 | SOC 2, HIPAA, AES-256; but US-only access; no AU support confirmed | **Total: 12/25 — ⭐⭐⭐ Good** *AU Fit gate: 1/5 — does not qualify for Excellent or Top Pick.* --- ## Frequently asked questions ### Is DeepScribe available in Australia? DeepScribe's availability in Australia is unconfirmed as of June 2026\. The company does not list Australia as a market, and all named customers are US health systems. Australian organisations interested in DeepScribe should contact the company directly at deepscribe.ai/contact to inquire about availability and AU data residency options. ### How much does DeepScribe cost? DeepScribe does not publish pricing. It is an enterprise product sold via custom quote to healthcare organisations. There is no individual clinician plan and no free trial. Third-party estimates suggest US enterprise ambient scribes range from US$300 to US$800 per provider per month, but this is not confirmed for DeepScribe specifically. ### Does DeepScribe work with Best Practice or MedicalDirector? No. DeepScribe's listed EHR integrations are US-specific — Epic, iKnowMed, OncoemR, and similar platforms. There is no confirmed integration with Best Practice or MedicalDirector, the two primary clinical software platforms used by Australian GPs and specialists. --- ## Sources - DeepScribe homepage: [https://www.deepscribe.ai/](https://www.deepscribe.ai/?ref=theaidirectory.com.au) — reviewed 26 June 2026 - DeepScribe security practices: [https://www.deepscribe.ai/security-practices](https://www.deepscribe.ai/security-practices?ref=theaidirectory.com.au) - DeepScribe privacy policy: [https://www.deepscribe.ai/privacy](https://www.deepscribe.ai/privacy?ref=theaidirectory.com.au) - DeepScribe EHR integrations: [https://www.deepscribe.ai/ehr-integrations](https://www.deepscribe.ai/ehr-integrations?ref=theaidirectory.com.au) - KLAS score reference: per DeepScribe website (98.8 KLAS Spotlight score as displayed on deepscribe.ai, June 2026) (vendor's own figure, not independently verified) - AUD exchange rate: approximately USD 1 = AUD 1.40 as of September 2026 (third-party estimate — not published by the vendor) --- --- *The AI Directory Australia is an independent editorial publication. We don't accept payment for positive reviews. Read our* [*Methodology*](https://www.theaidirectory.com.au/methodology/) *and* [*Affiliate Disclosure*](https://www.theaidirectory.com.au/affiliate-disclosure/)*.*